MIMS has issued its Dec medication update, highlighting important new products such as Eloctate, Empliciti, ephedrine hydrocholoride and Taitz.
There's a new contraindication for Soliris and a new indication for Humira plus a range of deleted products including Chemmart Famotidine, Ciprofloxacion Sandoz IV, Estraderm and GenRx Salbutamol Inhalation Ampoule.
See www.mims.com.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Dec 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Dec 16
